e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Progress in endoscopy for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer
N. Claessens, K. Maas, A. Kummer, F. Schramel (Nieuwegein, The Hague, Netherlands)
Source:
Annual Congress 2012 - Progress in endoscopy for lung cancer
Session:
Progress in endoscopy for lung cancer
Session type:
Poster Discussion
Number:
4403
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Claessens, K. Maas, A. Kummer, F. Schramel (Nieuwegein, The Hague, Netherlands). Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer. Eur Respir J 2012; 40: Suppl. 56, 4403
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007
Diagnostic yield of TBNA and contribution to conventional diagnostic procedures in endobronchial lesions of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 299s
Year: 2004
EUS-FNA as the first diagnostic procedure in lung cancer staging
Source: Annual Congress 2009 - The ultrasound view
Year: 2009
The influence of nodal size on EUS-FNA outcomes for mediastinal staging of NSCLC
Source: Annual Congress 2010 - Are needles enough: the value of different approaches
Year: 2010
EBUS-TBNA for mediastinal restaging
Source: Annual Congress 2006 - Lung cancer staging and miscellaneous
Year: 2006
Yield of real-time EBUS-TBNA in the diagnosis and staging of lung cancer
Source: Annual Congress 2005 - New techniques in diagnostic and therapeutic interventional pulmonology
Year: 2005
EBUS-TBNA
vs
mediastinoscopy for the staging of lung cancer
Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy
Year: 2006
Implementation of EUS-FNA for lung cancer staging
Source: Eur Respir J 2007; 30: Suppl. 51, 109s
Year: 2007
Negative predictive value of EBUS-TBNA in mediastinal staging of lung cancer
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Improving lung cancer staging with EUS-FNA
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Diagnostic yield of N3 hilar staging by endobronchial ultrasonography (EBUS) in lung cancer.
Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope
Year: 2018
EBUS-TBNA in lung cancer staging
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008
Does routine use of EBUS-TBNA and EUS-FNA improve the accuracy of staging of non small cell lung cancer patients – A national tumor registry based study
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
EUS-FNA and EBUS: the role of ultrasound in endoscopic diagnosis of mediastinal lymph nodes
Source: Annual Congress 2007 - EUS-FNA and EBUS: the role of ultrasound in endoscopic diagnosis of mediastinal lymph nodes
Year: 2007
The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC
Source: Eur Respir J 2005; 25: 410-415
Year: 2005
Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?
Source: Eur Respir J 2007; 30: Suppl. 51, 452s
Year: 2007
Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC.
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020
Assessment of the negative predictive value (NPV) of endobronchial ultrasound-guided real-time needle aspiration (EBUS-rtNA) in mediastinal lymph node staging in patients with lung cancer based on surgical results
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008
The role of number of lymph node passes and methods of pathological examination in the adequacy specimens of EBUS-TBNA in the verification of mediastinal lymphadenopathy
Source: Annual Congress 2013 –VATS, interventional endoscopy and tracheal surgery
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept